Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Cohance Lifesciences Ltd.
NSE: COHANCE
|
BSE: 543064
|
ISIN: INE03QK01018
|
Industry: Pharmaceuticals
|
Expensive Performer
452.6000
1.45
(
0.32
%)
NSE
Jul 02, 2026
15:31 PM
59.63% Fall from 52W High
Volume:
299.3K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Cohance Lifesciences Ltd.
10 May 2022
452.60
0.32%
Suven Pharmaceuticals
Hold:
Cohance Lifesciences Ltd.
by
ICICI Direct
Target: 555
ICICI Direct
Cohance Lifesciences Ltd. is trading
below its 200 day SMA
of 521.2
More from Cohance Lifesciences Ltd.
Recommended
Market closes higher on signs of progress in US-Iran talks
Trendlyne Marketwatch |
02 Jul 2026, 03:54PM
Q1FY27: What's driving the strongest growth forecasts?
The Baseline |
02 Jul 2026, 02:42PM
New threats: Risks for India are shifting from global to domestic
The Baseline |
02 Jul 2026, 11:30AM